NCT04277910View on ClinicalTrials.gov

A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

September 30, 2021

Conditions
Healthy
Interventions
DRUG

MT2004

MT2004 oral capsules

DRUG

Placebo

Placebo oral capsules

Trial Locations (1)

21201

Pharmaron CPC, Inc., Baltimore

All Listed Sponsors
lead

Xi'an Biocare Pharma Ltd.

OTHER

NCT04277910 - A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004 | Biotech Hunter | Biotech Hunter